Review



du145  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC du145
    Du145, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8547 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/du145/DU+145/pm42304957-32-8-18
    Average 99 stars, based on 8547 article reviews
    du145 - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    other:


    Cell Culture:

    Article Title: PARG inhibition in ATM-deficient prostate cancer: from mechanistic discovery to therapeutic potential.
    Article Snippet: .. PC3, DU145, 22Rv1, and C4-2B cell lines were obtained and cultured according to the ATCC recommendations. .. These cell lines were cultured in complete RPMI 1640 medium (Gibco) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin antibiotic solution.

    Article Title: Retinol dehydrogenase 11 promotes prostate cancer progression through upregulation of tropomyosin receptor kinase A.
    Article Snippet: .. Human PCa PC3 (1101HUM-PUMC000115, NSTI-BMCR, Beijing, China) and DU145 (1101HUMPUMC000006, NSTI-BMCR) cells and normal human prostate RWPE-2 (CRL-3608, ATCC) cells were cultured in DMEM medium (11965‐092, Gibco, Grand Island, NY, USA), while LNCaP (CL-0143, Procell, Wuhan, China) cells were cultured in RPMI Medium 1640 (61870-036, Gibco). ..

    Article Title: Lipid Metabolic Rewiring During Continuous Prostate Cancer Progression Defines a Biologically Relevant Four-Gene Prognostic Signature.
    Article Snippet: ImageJ software was used to quantify the positive staining area of Oil Red O, and the lipid content in the tumor tissues of the two groups was compared. .. Cell lines and cell culture Human prostate cancer cell lines LNCaP, VCaP, PC3, and DU145, as well as murine RM-1 cells, were obtained from American Type Culture Collection. ..

    Multiple Displacement Amplification:

    Article Title: Evidence for a Potential Context-Dependent Dual Role of Eb Peptide of IGF-1Eb in Cancer Cell Survival and Adaptation to UV Stress.
    Article Snippet: .. Six human cancer cell lines were employed in this study: MDA-MB-231 (triple-negative breast adenocarcinoma) (CN: ATCC-HTB-26, ATCC, Bethesda, MD, USA) and MCF-7 (ER-positive breast adenocarcinoma) (CN: ATCC-HTB-22, ATCC, Bethesda, MD, USA), PC-3 (androgen-independent, p53-null prostate adenocarcinoma) (CN: ATCC-CRL-1435, ATCC, Bethesda, MD, USA) and DU145 (androgen-independent prostate carcinoma) (CN: https://doi.org/10.3390/ijms27114793 ATCC-HTB-81, ATCC, Bethesda, MD, USA), and HepG2 (well-differentiated hepatocellular carcinoma) (CN: ATCC-HB-8065, ATCC, Bethesda, MD, USA) and Huh-7 (moderately differentiated hepatoma) (CN: 300156, Cytion, Heidelberg, Germany). .. All cell lines were purchased from the American Type Culture Collection (ATCC, Bethesda, MD, USA).



    Similar Products

    du145  (ATCC)
    99
    ATCC du145
    Du145, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/du145/DU+145/pm42304957-32-8-18
    Average 99 stars, based on 1 article reviews
    du145 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC du145 cells
    Panels A-I: Viability of VCaP cells, LNCaP cells or CWR22Rv1-AR-EK cells was determined at the indicated time points of treatment with vehicle or three concentrations of the enzalutamide, KCI807 or KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values. For statistical analysis, the treatment curves were compared in each case with the corresponding vehicle control as described under Methods. Panels J-M: Viability of the AR-negative <t>DU145</t> cells, MDA-MB-231 cells, HeLa cells and MDA-MB-231 cells was determined at the end of four days of treatment with vehicle and two concentrations of KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values, considering the Day 0 values to be 100 percent. Statistical analysis of the histograms, conducted as described under Methods, did not show significant effects of the compounds.
    Du145 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/du145/DU+145/bio_rxiv__64898__2026__05__26__727474-105-6-18
    Average 99 stars, based on 1 article reviews
    du145 cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    86
    Novartis du145 psma cell line
    Panels A-I: Viability of VCaP cells, LNCaP cells or CWR22Rv1-AR-EK cells was determined at the indicated time points of treatment with vehicle or three concentrations of the enzalutamide, KCI807 or KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values. For statistical analysis, the treatment curves were compared in each case with the corresponding vehicle control as described under Methods. Panels J-M: Viability of the AR-negative <t>DU145</t> cells, MDA-MB-231 cells, HeLa cells and MDA-MB-231 cells was determined at the end of four days of treatment with vehicle and two concentrations of KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values, considering the Day 0 values to be 100 percent. Statistical analysis of the histograms, conducted as described under Methods, did not show significant effects of the compounds.
    Du145 Psma Cell Line, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/du145/cancer+cell+encyclopedia+line/pm42159963-222-25-17
    Average 86 stars, based on 1 article reviews
    du145 psma cell line - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Novartis du145 cell line
    Panels A-I: Viability of VCaP cells, LNCaP cells or CWR22Rv1-AR-EK cells was determined at the indicated time points of treatment with vehicle or three concentrations of the enzalutamide, KCI807 or KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values. For statistical analysis, the treatment curves were compared in each case with the corresponding vehicle control as described under Methods. Panels J-M: Viability of the AR-negative <t>DU145</t> cells, MDA-MB-231 cells, HeLa cells and MDA-MB-231 cells was determined at the end of four days of treatment with vehicle and two concentrations of KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values, considering the Day 0 values to be 100 percent. Statistical analysis of the histograms, conducted as described under Methods, did not show significant effects of the compounds.
    Du145 Cell Line, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/du145/cancer+cell+encyclopedia+line/pm42159963-75-34-26
    Average 86 stars, based on 1 article reviews
    du145 cell line - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    Panels A-I: Viability of VCaP cells, LNCaP cells or CWR22Rv1-AR-EK cells was determined at the indicated time points of treatment with vehicle or three concentrations of the enzalutamide, KCI807 or KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values. For statistical analysis, the treatment curves were compared in each case with the corresponding vehicle control as described under Methods. Panels J-M: Viability of the AR-negative DU145 cells, MDA-MB-231 cells, HeLa cells and MDA-MB-231 cells was determined at the end of four days of treatment with vehicle and two concentrations of KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values, considering the Day 0 values to be 100 percent. Statistical analysis of the histograms, conducted as described under Methods, did not show significant effects of the compounds.

    Journal: bioRxiv

    Article Title: A Novel Drug Candidate that Selectively Targets the Critical Androgen Receptor-ELK1 Growth Axis in Advanced and Drug-Resistant Prostate Cancer

    doi: 10.64898/2026.05.26.727474

    Figure Lengend Snippet: Panels A-I: Viability of VCaP cells, LNCaP cells or CWR22Rv1-AR-EK cells was determined at the indicated time points of treatment with vehicle or three concentrations of the enzalutamide, KCI807 or KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values. For statistical analysis, the treatment curves were compared in each case with the corresponding vehicle control as described under Methods. Panels J-M: Viability of the AR-negative DU145 cells, MDA-MB-231 cells, HeLa cells and MDA-MB-231 cells was determined at the end of four days of treatment with vehicle and two concentrations of KCI838, as indicated, using a standard MTT assay conducted as described under Methods and values were plotted as percent of the Day 0 values, considering the Day 0 values to be 100 percent. Statistical analysis of the histograms, conducted as described under Methods, did not show significant effects of the compounds.

    Article Snippet: 22Rv1 cells, LNCaP cells, VCaP cells, DU145 cells, A549 cells, MDA-231 cells and HeLa cells were purchased from ATCC and frozen after less than 5 passages.

    Techniques: MTT Assay, Control